123 related articles for article (PubMed ID: 19251955)
1. Investigations into the lack of consensus in the reporting of HLA antibody specificities in the UK.
Wortley A; Mckinley K; Whittle R; Calvert A; Shaw O; Fernando R; Pearse A; Hopkins K; Clark B
J Clin Pathol; 2009 Mar; 62(3):270-4. PubMed ID: 19251955
[TBL] [Abstract][Full Text] [Related]
2. HLA antibody identification with single antigen beads compared to conventional methods.
El-Awar N; Lee J; Terasaki PI
Hum Immunol; 2005 Sep; 66(9):989-97. PubMed ID: 16360839
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
[TBL] [Abstract][Full Text] [Related]
4. [Experience on identification of cross-reactive group specificity performed by anti-human globulin panel reactive antibody tests].
Sohn YH; Cha CH; Kim MH; Ko SY; Oh HB
Korean J Lab Med; 2008 Oct; 28(5):362-70. PubMed ID: 18971617
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen proficiency testing for Central and Eastern Europe: a summary of over 10 years of activity.
Bogunia-Kubik K; Lange A
Transplant Proc; 2010 Oct; 42(8):3263-5. PubMed ID: 20970668
[TBL] [Abstract][Full Text] [Related]
6. Development of the HLA proficiency testing for Central and East Europe.
Bogunia-Kubik K; Lange A
Int J Immunogenet; 2008 Aug; 35(4-5):409-16. PubMed ID: 18976448
[TBL] [Abstract][Full Text] [Related]
7. Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine.
Colombo MB; Haworth SE; Poli F; Nocco A; Puglisi G; Innocente A; Serafini M; Messa P; Scalamogna M
Cytometry B Clin Cytom; 2007 Nov; 72(6):465-71. PubMed ID: 17397064
[TBL] [Abstract][Full Text] [Related]
8. Concordance and discordance in anti-HLA antibody testing.
Israeli M; Pollack MS; Shaut CA; Halpin A; DiPaola NR; Youngs D; Saidman SL;
Transpl Immunol; 2015 Jan; 32(1):1-8. PubMed ID: 25460810
[TBL] [Abstract][Full Text] [Related]
9. Differential immunogenicity of HLA class I alloantigens for the humoral versus the cellular immune response: "towards tailor-made HLA mismatching".
Claas FH; Roelen DL; Mulder A; Doxiadis II; Oudshoorn M; Heemskerk M
Hum Immunol; 2006 Jun; 67(6):424-9. PubMed ID: 16728264
[TBL] [Abstract][Full Text] [Related]
10. ELISA methods detect HLA antibodies with variable sensitivity.
Monien S; Salama A; Schönemann C
Int J Immunogenet; 2006 Jun; 33(3):163-6. PubMed ID: 16712645
[TBL] [Abstract][Full Text] [Related]
11. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
Reil A; Keller-Stanislawski B; Günay S; Bux J
Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
[TBL] [Abstract][Full Text] [Related]
12. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. I. HLA-A,B,C typing, antibody screening, and lymphocytotoxicity crossmatching. American Society for Histocompatibility and Immunogenetics. College of American Pathologists.
Marrari M; Duquesnoy RJ
Hum Immunol; 1994 Feb; 39(2):87-95. PubMed ID: 8175387
[TBL] [Abstract][Full Text] [Related]
13. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males.
Morales-Buenrostro LE; Terasaki PI; Marino-Vázquez LA; Lee JH; El-Awar N; Alberú J
Transplantation; 2008 Oct; 86(8):1111-5. PubMed ID: 18946350
[TBL] [Abstract][Full Text] [Related]
14. Quality control for registry HLA data.
Tiercy JM; Fischer G; Setterholm M
Tissue Antigens; 2007 Apr; 69 Suppl 1():13-4. PubMed ID: 17445155
[TBL] [Abstract][Full Text] [Related]
15. HLA class II DP epitopes.
Deng CT; Cai J; Ozawa M; El-Awar N
Clin Transpl; 2007; ():195-202. PubMed ID: 18637470
[TBL] [Abstract][Full Text] [Related]
16. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
Sasaki N; Idica A; Hall B; Terasaki PI
Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
[TBL] [Abstract][Full Text] [Related]
17. HLA-typing analysis following allogeneic bone grafting for sinus lifting.
Piaia M; Bub CB; Succi GM; Torres M; Costa TH; Pinheiro FC; Napimoga MH
Cell Tissue Bank; 2017 Mar; 18(1):75-81. PubMed ID: 27783263
[TBL] [Abstract][Full Text] [Related]
18. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
Süsal C; Döhler B; Opelz G
Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
[TBL] [Abstract][Full Text] [Related]
19. [Development of a web-based program for the identification of human leukocyte antigen antibody specificities].
Cha CH; Oh HB; Kim MH; Chae JM; Jung SY
Korean J Lab Med; 2007 Dec; 27(6):458-63. PubMed ID: 18160837
[TBL] [Abstract][Full Text] [Related]
20. Unexpected frequencies of HLA antibody specificities present in sera of multitransfused patients.
Idica A; Sasaki N; Hardy S; Terasaki P
Clin Transpl; 2006; ():139-59. PubMed ID: 18365375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
